Monday, 2 November 2026
Venture Intelligence News

M&A

M&A

Kilitch Drugs to divest Ethiopian subsidiary for $14-M

Mumbai-headquartered, publicly listed Kilitch Drugs is to divest its entire shareholding in its Ethiopian subsidiary, Kilitch Estro Biotech, to the Ethiopian state-owned enterprise HarmeeCare Pharmaceuticals, for USD…